Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Revvity Inc. (RVTY:NYSE), powered by AI.
Revvity Inc. is currently trading at $101.22. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Revvity Inc. on Alpha Lenz.
Revvity Inc.'s P/E ratio is 48.9.
“Revvity Inc. trades at a P/E of 48.9 (premium valuation) with modest ROE of 3.2%.”
Ask for details →Revvity Inc. is a prominent company in the healthcare and biological sciences field, offering a comprehensive suite of solutions aimed at improving global health outcomes. The company's core focus lies in delivering innovative products and services that range from diagnostic tools to advanced analytical capabilities for life sciences research. Revvity serves a wide array of sectors including biotechnology, pharmaceuticals, and clinical diagnostics, providing essential tools and data analytics that aid in disease discovery, drug development, and health monitoring. The company's expertise in deploying cutting-edge technologies further reinforces its position as a critical enabler of scientific research and innovation. With its global reach and commitment to enhancing healthcare delivery, Revvity Inc. plays a pivotal role in advancing the capabilities of medical and scientific communities worldwide, driving progress in critical areas such as personalized medicine and preventive healthcare.
“Revvity Inc. trades at a P/E of 48.9 (premium valuation) with modest ROE of 3.2%.”
Ask for details →Revvity Inc. (ticker: RVTY) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 11,000 employees. Market cap is $11.8B.
The current price is $101.22 with a P/E ratio of 48.91x and P/B of 1.63x.
ROE is 3.23% and operating margin is 12.49%. Annual revenue is $2.9B.